LK
Lakefront Biotherapeutics N.V.
LKFT · NASDAQ
$28.55 -0.76% (-$0.22)
1M -1.69%
Market Cap 1.64B €
P/E Ratio 2.75x
Div. Yield -
ROE 19.58%
Bulios Fair Price
$28.02
1.9% downside
Current Price
$28.55
Undervalued Fair Value Overvalued
According to Bulios Fair Price, LKFT is currently trading close to its fair value. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
4/9Valuation
98 /100
Cheap P/E 2.75x
P/B 0.50x
EV/EBITDA 2.84x
Growth
7 /100
Declining Rev. growth 20.55%
Book val. growth 1.54%
EPS growth N/A
Profitability
70 /100
Strong Gross margin 94.88%
FCF margin 19.93%
Net margin 60.23%
Quality
86 /100
Excellent ROIC 39,505.80%
Asset turnover 0.30x
ROE 19.58%
Debt
100 /100
Low Debt/Equity 0.00x
Net debt/EBITDA -0.24x
Current ratio 32.82x
Stability
18 /100
Unstable Beta 0.12x
Profitable years 3
Rev. volatility 29.25%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about LKFT
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Henry O. Gosebruch
Employees
452
Headquarters
Mechelen
Upcoming events
12 NOV
Earnings
Upcoming earnings report